QQ客服 官方微博 反馈留言

	Engineering chimeric antigen receptor-T cells for cancer treatment
	Ye, Baixin; Stary, Creed M.; Li, Xuejun; Gao, Qingping; Kang, Chunsheng*; Xiong, Xiaoxing*
刊名	Molecular Cancer
	2018
卷号	17期号:1页码:32
关键词	Tumor ecosystem Intratumor heterogeneity T-cell exhaustion Cancer immunotherapy Chimeric antigen receptor (CAR) T cell therapy
ISSN号	1476-4598
DOI	10.1186/s12943-018-0814-0
URL标识	查看原文
WOS记录号	WOS:000425758000001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3341574
专题	中南大学
作者单位	1.[Gao, Qingping 2.Ye, Baixin] Wuhan Univ, Renmin Hosp, Dept Hematol, Wuhan 430060, Hubei, Peoples R China.
推荐引用方式 GB/T 7714	Ye, Baixin,Stary, Creed M.,Li, Xuejun,et al. Engineering chimeric antigen receptor-T cells for cancer treatment[J]. Molecular Cancer,2018,17(1):32.
APA	Ye, Baixin,Stary, Creed M.,Li, Xuejun,Gao, Qingping,Kang, Chunsheng*,&Xiong, Xiaoxing*.(2018).Engineering chimeric antigen receptor-T cells for cancer treatment.Molecular Cancer,17(1),32.
MLA	Ye, Baixin,et al."Engineering chimeric antigen receptor-T cells for cancer treatment".Molecular Cancer 17.1(2018):32.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。